CBDS Digital Health Seminar Series: "Digital Health Regulation and Policy"
Jarrin will discuss current policy and regulatory developments in the exciting field of digital health and medicine. Topics will include Medicare reimbursement for remote physiologic monitoring treatment management services and other federal incentives for the use of digital tools. The discussion will provide an overview of how the American Medical Association Current Procedural Terminology (CPT®) coding is helping to advance digital medical services. Mr. Jarrin will also discuss FDA regulation of digital medical devices as well as agency deregulatory actions specific to mobile medical apps, software as a medical device (SaMD), and clinical decision support (CDS), as well as regulatory trends in artificial intRobert Jarrin is a strategic advisor to companies and associations on digital medicine and life sciences.
Qualcomm, Inc.Robert Jarrin, JDSenior Director of Government Affairs